MARK SULTZMAN: Open Payments
NPI 1841524527 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 12 payments from 9 companies in 2025. Trend: 2023 $313 · 2024 $326 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $57 |
| Amgen Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| Lundbeck LLC | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
| Boston Scientific Corporation | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Smith+Nephew, Inc. | 1 | $15 |
Products named: Ozempic, EVENITY, FARXIGA, VYEPTI, Exparel, QULIPTA, Varithena Administration Pack, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
